جارٍ التحقق…
تُرجمت تلقائيًا. للجرعات والتحذيرات: راجع النص الأصلي بالإنجليزية. اقرأ بالإنجليزية

Ciprofloxacin

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the c.

ز - الأدوية التي تصرف بموجب وصفة طبية Ophthalmic Safety alerts on record

How to use Ciprofloxacin

ما تقوله النشرة الرسمية. إذا وصفه لك طبيب، فاتبع الوصفة. وإذا اختلفت نشرة عبوتك، فالأولوية لها.

لمن هو

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae *Efficacy for this organism was studied in fewer than 10 infections.

كيف يُتناول وكم مرة
  • Corneal Ulcers: The recommended dosage regimen
  • For the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day
  • On the second day, instill two drops in the affected eye hourly
  • On the third through the fourteenth day, place two drops in the affected eye every four hours
  • Treatment may be continued after 14 days if corneal re-epithelialisation has not occurred
  • Bacterial Conjunctivitis: The recommended dosage regimen
  • For the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days
Children
  • The safety and effectiveness of Ciprofloxacin ophthalmic solution 0.3% have been established in all ages
  • Use of Ciprofloxacin ophthalmic solution is supported by evidence from adequate and well controlled studies of Ciprofloxacin ophthalmic solution
  • In adults, children and neonates [ see Clinical Studies ]. …
Older adults

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

While you are taking it

Do not touch dropper tip to any surface, as this may contaminate the solution.

Talk to a doctor first if
  • A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use
  • A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin
Medicines it may not mix with

Specific drug interaction studies have not been conducted with ophthalmic ciprofloxacin. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant, warfarin, and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.

Warnings

NOT FOR INJECTION INTO THE EYE. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated. …

الآثار الجانبية المحتملة

The most frequently reported drug related adverse reaction was local burning or discomfort. In corneal ulcer studies with frequent administration of the drug, white crystalline precipitates were seen in approximately 17% of patients ( see Precautions ). Other reactions occurring in less than 10% of patients included lid margin crusting, crystals/scales, foreign body sensation, itching, conjunctival hyperemia and a bad taste following instillation. Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision. …

If you take too much

A topical overdose of ciprofloxacin Ophthalmic Solution may be flushed from the eye(s) with warm tap water.

إذا نسيت جرعة

تناولها عندما تتذكر، إلا إذا اقترب موعد الجرعة التالية. عندها تخطَّ الجرعة المنسية. لا تتناول جرعتين معًا أبدًا للتعويض. راجع النشرة، فبعض الأدوية مختلفة.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-05-02.

الأسماء التجارية حول العالم

Products with Ciprofloxacin as the active ingredient. Names differ between countries.

Registered products

United States (FDA)

CiprofloxacinCIPROFLOXACIN HYDROCHLORIDE 250 mg/1 · Tablet · PD-Rx Pharmaceuticals, Inc.
NDC 43063-410Label
CiprofloxacinCIPROFLOXACIN HYDROCHLORIDE 500 mg/1 · Tablet · Direct_Rx
NDC 72189-623Label
CiprofloxacinCIPROFLOXACIN 1 kg/kg · Powder · Quimica Sintetica S.A.
NDC 53069-0680Label
Ciprofloxacin Hydrochloride CompactedCIPROFLOXACIN HYDROCHLORIDE 1 kg/kg · Powder · Quimica Sintetica S.A.
NDC 53069-0690Label
CiprofloxacinCIPROFLOXACIN HYDROCHLORIDE 500 mg/1 · Tablet, Film Coated · HAWAII REPACK, INC.
NDC 85534-0047Label

Nigeria (NAFDAC)

NAFDACCiprofloxacin Tablet C4-1237NAFDACCiprofloxacin Tablet C4-1236NAFDACCiprofloxacin Tablets C4-1545NAFDACCiprofloxacin Caplets C4-1863NAFDACCiprofloxacin Caplets_ C4-1863NAFDACCiprofloxacin Eye Drops A4-8400NAFDACCiprofloxacin IV Infusion C4-1567NAFDACCiprofloxacin 500 mg Tablet B4-6438NAFDACCiprofloxacin 500 mg Tablet B4-1176NAFDACCiprofloxacin Eye/Ear Drops C4-1637NAFDACCiprofloxacin 500 mg Tablet A11-100887NAFDACCiprofloxacin 500 mg Tablets C4-1602

Other countries: check your pack's registration number and we point you to your regulator.

Safety alerts and recalls

Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., PrincetoU.S. FDA Class II
13 Aug 2025 · Sandoz Inc · OngoingTemperature Abuse
CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05.U.S. FDA Class II
31 Jan 2025 · Direct Rx · OngoingDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra,U.S. FDA Class II
11 Mar 2025 · FDC Limited · OngoingDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, Sterile, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, MahU.S. FDA Class II
16 Dec 2024 · FDC Limited · OngoingDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

A recall usually affects certain batches only. Compare the lot number on your pack.

Check your pack of Ciprofloxacin

أو التقط صورًا للعبوة
تبقّت 3 عمليات تحقق مجانية اليوم المصادر الرسمية: FDA الأمريكية · EMA (الاتحاد الأوروبي) · NAFDAC · تنبيهات منظمة الصحة العالمية

Questions about Ciprofloxacin

What is Ciprofloxacin used for?

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aureus Staphylococcus ep (From the official U.S. FDA label.)

How do I take Ciprofloxacin?

Follow your prescription or the leaflet in your pack. The official label says: Corneal Ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth day, place two drops in th…

Do I need a prescription for Ciprofloxacin?

Usually yes. Ciprofloxacin is a prescription medicine in most countries. Rules differ by country.

What brands contain Ciprofloxacin?

Ciprofloxacin is sold under names such as Otovel, Cipro, Ciloxan, Cipro Hc, Ciprodex, Proquin, Cetraxal, Ciprofloxacin. Brand names differ between countries.

How can I check that my Ciprofloxacin is genuine?

Scan the registration number on your pack with PillVera (NAFDAC number in Nigeria, NDC in the United States, DIN in Canada), check the expiry date and buy only from licensed pharmacies.